Release Date: 26/02/15 18:46 Summary: Appendix 4D & Half-Year Financial Statements Price Sensitive: Yes Download Document 538.83KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%